Based on the above results, we concluded that METTL3 promoted the processing of pri-miR-192-5p into mature miR-192-5p to target SCD1 to affect lipid metabolism, further regulating T cell differentiation and facilitating asthma development, which may provide a novel therapeutic strategy for asthma. The gene discussed is METTL3; the disease is asthma.